Europe Coagulation Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand\'s Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), and End User (Clinical Laboratories, Hospitals, and Others)

No. of Pages: 116    |    Report Code: BMIRE00029855    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Coagulation Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Coagulation Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Coagulation Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Prevalence of Blood Disorders
  • 5.1.2 Rising Incidence of Cardiovascular Diseases
5.2 Market Opportunities
  • 5.2.1 Growing Organic and Inorganic Strategies by Key Market Players
5.3 Future Trends
  • 5.3.1 Development of Point-of-Care (POC) Coagulation Analyzers
5.4 Impact of Drivers and Restraints

6. Europe Coagulation Market Regional Analysis

6.1 Europe Coagulation Market Overview
6.2 Europe Coagulation Market Revenue 2020-2030 (US$ Million)
6.3 Europe Coagulation Market Forecast Analysis

7. Europe Coagulation Market Analysis – by Disease Indications

7.1 Vitamin K Deficiency
  • 7.1.1 Overview
  • 7.1.2 Vitamin K Deficiency: Europe Coagulation Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Liver Disease
  • 7.2.1 Overview
  • 7.2.2 Liver Disease: Europe Coagulation Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Disseminated Intravascular Coagulation & Pulmonary Embolism
  • 7.3.1 Overview
  • 7.3.2 Disseminated Intravascular Coagulation & Pulmonary Embolism: Europe Coagulation Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Development of Circulating Anticoagulants
  • 7.4.1 Overview
  • 7.4.2 Development of Circulating Anticoagulants: Europe Coagulation Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Hemophilia
  • 7.5.1 Overview
  • 7.5.2 Hemophilia: Europe Coagulation Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Von Willebrand\'s Disease
  • 7.6.1 Overview
  • 7.6.2 Von Willebrand\'s Disease: Europe Coagulation Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Coagulation Market Analysis – by Type

8.1 Clinical Laboratory Analyzers
  • 8.1.1 Overview
  • 8.1.2 Clinical Laboratory Analyzers: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Point-of-Care Testing Analyzers
  • 8.2.1 Overview
  • 8.2.2 Point-of-Care Testing Analyzers: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

9. Europe Coagulation Market Analysis – by Offering

9.1 Prothrombin Time Testing
  • 9.1.1 Overview
  • 9.1.2 Point-of-Care Testing Analyzers: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Fibrinogen Testing
  • 9.2.1 Overview
  • 9.2.2 Point-of-Care Testing Analyzers: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Activated Clotting Time Testing
  • 9.3.1 Overview
  • 9.3.2 Point-of-Care Testing Analyzers: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Activated Partial Thromboplastin Time Testing
  • 9.4.1 Overview
  • 9.4.2 Point-of-Care Testing Analyzers: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.5 D-Dimmer Testing
  • 9.5.1 Overview
  • 9.5.2 Point-of-Care Testing Analyzers: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Platelets Function Testing
  • 9.6.1 Overview
  • 9.6.2 Point-of-Care Testing Analyzers: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

10. Europe Coagulation Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Coagulation Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 Europe Coagulation Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 UK: Europe Coagulation Market Breakdown, by Disease Indications
    • 10.1.1.1.2 UK: Europe Coagulation Market Breakdown, by Type
    • 10.1.1.1.3 UK: Europe Coagulation Market Breakdown, by Offering
  • 10.1.1.2 Germany: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Coagulation Market Breakdown, by Disease Indications
    • 10.1.1.2.2 Germany: Europe Coagulation Market Breakdown, by Type
    • 10.1.1.2.3 Germany: Europe Coagulation Market Breakdown, by Offering
  • 10.1.1.3 France: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 France: Europe Coagulation Market Breakdown, by Disease Indications
    • 10.1.1.3.2 France: Europe Coagulation Market Breakdown, by Type
    • 10.1.1.3.3 France: Europe Coagulation Market Breakdown, by Offering
  • 10.1.1.4 Russia: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Coagulation Market Breakdown, by Disease Indications
    • 10.1.1.4.2 Russia: Europe Coagulation Market Breakdown, by Type
    • 10.1.1.4.3 Russia: Europe Coagulation Market Breakdown, by Offering
  • 10.1.1.5 Italy: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Coagulation Market Breakdown, by Disease Indications
    • 10.1.1.5.2 Italy: Europe Coagulation Market Breakdown, by Type
    • 10.1.1.5.3 Italy: Europe Coagulation Market Breakdown, by Offering
  • 10.1.1.6 Rest of Europe: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Coagulation Market Breakdown, by Disease Indications
    • 10.1.1.6.2 Rest of Europe: Europe Coagulation Market Breakdown, by Type
    • 10.1.1.6.3 Rest of Europe: Europe Coagulation Market Breakdown, by Offering

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Coagulation Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Genrui Biotech Co., Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Horiba Ltd.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 ImproGen Diagnostik Kimya San. & Tic. Ltd.ti
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Nordic Biomarker AB
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Siemens Healthineers AG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Sysmex Corp
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Transasia Bio-Medicals Ltd
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

1. F. Hoffmann-La Roche Ltd

2. Genrui Biotech Co., Ltd

3. Horiba Ltd.

4. ImproGen Diagnostik Kimya San. & Tic. Ltd.?ti

5. Nordic Biomarker AB

6. Siemens Healthineers AG

7. Sysmex Corp

8. Transasia Bio-Medicals Ltd

 

 

europe-coagulation-market